|
| 34718468 | A Randomized, Placebo-Controlled Clinical Trial of Bamlanivimab and Etesevimab Together in High-Risk Ambulatory Patients With COVID-19 and Validation of the Prognostic Value of Persistently High Viral Load. | Clin Infect Dis | 2022 |
| 36106611 | The ATEAM study: Advances in technology to enhance PrEP adherence monitoring (ATEAM) among young men who have sex with men. | Clin Transl Sci | 2022 |
| 36083883 | COVID-19 symptom relationship to antibody response and ACE2 neutralization in recovered health systems employees before and after mRNA BNT162b2 COVID-19 vaccine. | PLoS ONE | 2022 |
| 34877366 | Excess Weight Gain With Integrase Inhibitors and Tenofovir Alafenamide: What Is the Mechanism and Does It Matter? | Open Forum Infectious Diseases | 2021 |
| 33475701 | Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19: A Randomized Clinical Trial. | JAMA | 2021 |
| 33843803 | A Dual-Platform Point-of-Care Test for Neurosyphilis Diagnosis. | Sex Transm Dis | 2021 |
| 34260849 | Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19. | N Engl J Med | 2021 |
| 32648078 | A Novel Score to Predict Esophageal Varices in Patients with Compensated Advanced Chronic Liver Disease. | Digestive Diseases and Sciences | 2021 |
| 33113295 | SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19. | New England Journal of Medicine | 2021 |
| 34956222 | Endogenous Antibody Responses to SARS-CoV-2 in Patients With Mild or Moderate COVID-19 Who Received Bamlanivimab Alone or Bamlanivimab and Etesevimab Together. | Frontiers in Immunology | 2021 |
| 34374951 | A Narrative Review of the Clinical Practicalities of Bamlanivimab and Etesevimab Antibody Therapies for SARS-CoV-2. | Infectious Diseases and Therapy | 2021 |
| 32821939 | Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19: A Randomized Clinical Trial. | JAMA | 2020 |
| 31950070 | Atherosclerotic Cardiovascular Disease Risk Profile of Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate. | Open Forum Infectious Diseases | 2020 |
| 32352586 | Impact of a digital medicine programme on hepatitis C treatment adherence and efficacy in adults at high risk for non-adherence. | Aliment Pharmacol Ther | 2020 |
| 32053682 | Real-world efficacy of direct acting antiviral therapies in patients with HIV/HCV. | PLoS One | 2020 |
| 31995556 | HIV/HCV therapy with ledipasvir/sofosbuvir after randomized switch to emtricitabine-tenofovir alafenamide-based single-tablet regimens. | PLoS ONE | 2020 |
| 31879782 | Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in a Rapid-Initiation Model of Care for Human Immunodeficiency Virus Type 1 Infection: Primary Analysis of the DIAMOND Study. | Clinical Infectious Diseases | 2020 |
| 33528318 | Week 96 subgroup analyses of the phase 3, randomized AMBER and EMERALD trials evaluating the efficacy and safety of the once daily darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) single-tablet regimen in antiretroviral treatment (ART) | HIV Research and Clinical Practice | 2020 |
| 31464642 | Darunavir/cobicistat/emtricitabine/tenofovir alafenamide in treatment-experienced, virologically suppressed patients with HIV-1: subgroup analyses of the phase 3 EMERALD study. | AIDS Research and Therapy | 2019 |
| 30382942 | Daclatasvir and sofosbuvir with ribavirin for 24 weeks in chronic hepatitis C genotype-3-infected patients with cirrhosis: a Phase III study (ALLY-3C). | Antiviral Therapy | 2019 |
| 31093649 | Pharmacokinetics of tenofovir monoester and association with intracellular tenofovir diphosphate following single-dose tenofovir disoproxil fumarate. | Journal of Antimicrobial Chemotherapy | 2019 |
| 30968054 | Steatosis Rates by Liver Biopsy and Transient Elastography With Controlled Attenuation Parameter in Clinical Experience of Hepatitis C Virus (HCV) and Human Immunodeficiency Virus/HCV Coinfection in a Large US Hepatitis Clinic. | Open Forum Infectious Diseases | 2019 |
| 29304196 | Contribution of Liver Fibrosis and Microbial Translocation to Immune Activation in Persons Infected With HIV and/or Hepatitis C Virus. | Journal of Infectious Diseases | 2018 |
| 30047286 | Short Communication: Bioequivalence of Tenofovir and Emtricitabine After Coencapsulation with the Proteus Ingestible Sensor. | AIDS Research and Human Retroviruses | 2018 |
| 27753684 | A Randomized, Open-Label Trial to Evaluate Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Plus Darunavir in Treatment-Experienced HIV-1-Infected Adults. | J Acquir Immune Defic Syndr | 2017 |
| 26621911 | Association of HIV, Hepatitis C Virus, and Liver Fibrosis Severity With the Enhanced Liver Fibrosis Score. | Journal of Infectious Diseases | 2016 |
| 27459733 | Nephrotoxicity Associated with Concomitant Use of Ledipasvir-Sofosbuvir and Tenofovir in a Patient with Hepatitis C Virus and Human Immunodeficiency Virus Coinfection. | Pharmacotherapy | 2016 |
| 26538525 | Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in antiretroviral regimens for virologically suppressed adults with HIV-1 infection: a randomised, active-controlled, multicentre, open-label, phase 3, non-inferiority study. | Lancet Infect Dis | 2016 |
| 26251759 | Direct and Indirect Serum Markers of Liver Fibrosis Compared with Transient Elastography among Women in the Women's Interagency HIV Study. | Journal of AIDS and Clinical Research (discontinued) | 2015 |
| 25884329 | A matched cross-sectional study of the association between circulating tissue factor activity, immune activation and advanced liver fibrosis in hepatitis C infection. | BMC Infect Dis | 2015 |
| 25881614 | Simplification from twice-daily to once-daily darunavir/ritonavir in a randomized trial among HIV-infected persons with HIV-1 RNA suppression on antiretroviral therapy. | Antiviral Therapy | 2015 |
| 25870985 | Association of HIV, hepatitis C virus and liver fibrosis severity with interleukin-6 and C-reactive protein levels. | AIDS | 2015 |
| 23741991 | Evaluation of cardiovascular biomarkers in a randomized trial of fosamprenavir/ritonavir vs. efavirenz with abacavir/lamivudine in underrepresented, antiretroviral-naïve, HIV-infected patients (SUPPORT): 96-week results. | BMC Infectious Diseases | 2013 |
| 23901097 | Association of HIV infection, hepatitis C virus infection, and metabolic factors with liver stiffness measured by transient elastography. | Journal of Infectious Diseases | 2013 |
| 23970744 | Providers' lack of knowledge about herpes zoster in HIV-infected patients is among barriers to herpes zoster vaccination. | International Journal of STD and AIDS | 2013 |
| 24131865 | Characterization of CD4⺠T-cell immune activation and interleukin 10 levels among HIV, hepatitis C virus, and HIV/HCV-coinfected patients. | J Acquir Immune Defic Syndr | 2013 |
| 21767710 | Phaeomycotic cysts caused by Phoma species. | Diagnostic Microbiology and Infectious Disease | 2011 |
| 21051598 | The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. | Science | 2010 |
| 21156072 | Early development of non-hodgkin lymphoma following initiation of newer class antiretroviral therapy among HIV-infected patients - implications for immune reconstitution. | AIDS Research and Therapy | 2010 |
| 18607308 | Factors associated with newly diagnosed HIV among persons with concomitant sexually transmitted diseases. | Sexually Transmitted Diseases | 2008 |
| 18252104 | Spectrum of infection and risk factors for human monkeypox, United States, 2003. | Emerging Infectious Diseases | 2007 |
| 17080372 | Outbreak of bloodstream infection with the mold Phialemonium among patients receiving dialysis at a hemodialysis unit. | Infection Control and Hospital Epidemiology | 2006 |
| 16182416 | Vaccination coverage survey versus administrative data in the assessment of mass yellow fever immunization in internally displaced persons--Liberia, 2004. | Vaccine | 2006 |
| 16804861 | Rash as a prognostic factor in West Nile virus disease. | Clinical Infectious Diseases | 2006 |
| 16941343 | Clinical manifestations of human monkeypox influenced by route of infection. | Journal of Infectious Diseases | 2006 |
| 16318710 | Myocarditis Outbreak among Adults, Illinois, 2003. | Emerging Infectious Diseases | 2005 |
| 15866767 | Two outbreaks of occupationally acquired histoplasmosis: more than workers at risk. | Environmental Health Perspectives | 2005 |
| 16086890 | Outbreak of travel-related pontiac fever among hotel guests illustrating the need for better diagnostic tests. | Journal of Travel Medicine | 2005 |
| 15964962 | The emergence of west nile virus during a large outbreak in Illinois in 2002. | American Journal of Tropical Medicine and Hygiene | 2005 |
| 16288398 | Clinical characteristics of human monkeypox, and risk factors for severe disease. | Clinical Infectious Diseases | 2005 |